Handelsbanken Fonder Ab Ac Immune Sa Transaction History
Handelsbanken Fonder Ab
- $24.3 Billion
- Q1 2025
A detailed history of Handelsbanken Fonder Ab transactions in Ac Immune Sa stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 130,000 shares of ACIU stock, worth $278,200. This represents 0.0% of its overall portfolio holdings.
Number of Shares
130,000
Previous 150,000
13.33%
Holding current value
$278,200
Previous $405,000
40.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ACIU
# of Institutions
42Shares Held
26.7MCall Options Held
4.8KPut Options Held
22.2K-
Bvf Inc San Francisco, CA19.8MShares$42.4 Million1.63% of portfolio
-
Black Rock Inc. New York, NY2.61MShares$5.58 Million0.0% of portfolio
-
Wells Fargo & Company San Francisco, CA998KShares$2.13 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny803KShares$1.72 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA412KShares$881,0290.0% of portfolio
About AC Immune SA
- Ticker ACIU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,413,504
- Market Cap $179M
- Description
- AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...